Novo Nordisk
NVO
483 hedge funds and large institutions have $5.59B invested in Novo Nordisk in 2016 Q4 according to their latest regulatory filings, with 72 funds opening new positions, 122 increasing their positions, 213 reducing their positions, and 93 closing their positions.
3.07% less ownership
Funds ownership: 18.56% → 15.49% (-3.1%)
6% less funds holding
Funds holding: 513 → 483 (-30)
23% less first-time investments, than exits
New positions opened: 72 | Existing positions closed: 93
28% less capital invested
Capital invested by funds: $7.77B → $5.59B (-$2.18B)
43% less repeat investments, than reductions
Existing positions increased: 122 | Existing positions reduced: 213
43% less funds holding in top 10
Funds holding in top 10: 14 → 8 (-6)
59% less call options, than puts
Call options by funds: $13.1M | Put options by funds: $31.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$140M |
| 2 |
Two Sigma Advisers
New York
|
+$96.7M |
| 3 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
+$58.2M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$30.5M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$27.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM Investment Management
Laguna Beach,
California
|
-$335M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$276M |
| 3 |
Jennison Associates
New York
|
-$267M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$106M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$90.5M |
NVO Hedge Fund Activity: Q4 2016 in Review
483 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q4 2016, worth a combined $5.59B — down 28% from $7.77B a quarter earlier.
Sellers outnumbered buyers: 93 funds closed out of NVO and 72 opened new positions — a net loss of 21 holders — while 213 trimmed existing stakes and 122 added.
The largest buyer was Loomis, Sayles & Company, adding an estimated $140M. The largest seller was WCM Investment Management, cutting an estimated $335M.
- 483 institutional investors held Novo Nordisk (NVO) as of Q4 2016, down from 513 in Q3 2016.
- Funds reported $5.59B of Novo Nordisk stock for Q4 2016, down 28% quarter-over-quarter.
- 72 funds opened new Novo Nordisk positions in Q4 2016 and 93 closed out, a net change of -21 holders.
- The largest Novo Nordisk buyer in Q4 2016 was Loomis, Sayles & Company, an estimated $140M added.
- The largest Novo Nordisk seller in Q4 2016 was WCM Investment Management, an estimated $335M sold.
Based on aggregated 13F filings for Q4 2016.